-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KPI-012 in Persistent Corneal Epithelial Defects
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KPI-012 in Persistent Corneal Epithelial Defects report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KPI-012 in Persistent Corneal Epithelial Defects Drug Details: KPI-012...
-
Product Insights
Persistent Corneal Epithelial Defects – Drugs In Development, 2023
Global Markets Direct’s, ‘Persistent Corneal Epithelial Defects - Drugs In Development, 2023’, provides an overview of the Persistent Corneal Epithelial Defects pipeline landscape. The report provides comprehensive information on the therapeutics under development for Persistent Corneal Epithelial Defects, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KIO-201 in Persistent Corneal Epithelial Defects
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KIO-201 in Persistent Corneal Epithelial Defects Drug Details: KIO-201 was under development for the treatment...
-
Product Insights
NewLikelihood of Approval Analysis for Treatment Resistant Depression
Overview How likely is it that the drugs in Treatment Resistant Depression will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Treatment Resistant Depression Overview Treatment-resistant depression (TRD) refers to a form...
-
Product Insights
NewLikelihood of Approval Analysis for Generalized Anxiety Disorder (GAD)
Overview How likely is it that the drugs in Generalized Anxiety Disorder (GAD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Generalized Anxiety Disorder (GAD) Overview Generalized anxiety disorder is a...
-
Company Insights
Innovation and Patenting activity of Persistent Systems Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Persistent Systems Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval Analysis for Hypereosinophilic Syndrome
Overview How likely is it that the drugs in Hypereosinophilic Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypereosinophilic Syndrome Overview Hypereosinophilic syndrome (HES) is a disease characterized by a...
-
Product Insights
NewLikelihood of Approval Analysis for Anxiety Disorders
Overview How likely is it that the drugs in Anxiety Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anxiety Disorders Overview Anxiety disorders are a group of mental health conditions...
-
Product Insights
NewLikelihood of Approval Analysis for Mycobacterium tuberculosis Infections
Overview How likely is it that the drugs in Mycobacterium tuberculosis Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycobacterium tuberculosis Infections Overview The group of infections caused by Mycobacterium...
-
Product Insights
NewLikelihood of Approval Analysis for Major Depressive Disorder
Overview How likely is it that the drugs in Major Depressive Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Major Depressive Disorder Overview Major Depressive Disorder (MDD) is a common...